We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Alexion To Pay $25M To Settle Soliris Suit

Law360 (January 5, 2009, 12:00 AM EST) -- Biopharmaceutical firm Alexion Pharmaceuticals Inc. has agreed to pay $25 million to PDL BioPharma Inc. as part of a licensing deal that resolves PDL’s patent infringement suit over Alexion’s blood disorder...
To view the full article, register now.